macrophage Search Results


94
R&D Systems m1 macrophages
CM from CAFs exposed to apoptotic cancer cells reduces M2 macrophage survival, induces apoptosis, and promotes reprogramming toward an <t>M1</t> phenotype in vitro . ( a, b ) Cell viability assay of M1 (M1) or M2 <t>macrophages</t> (M2) derived from THP-1 cells and BMDMs. ( c, d ) Apoptotic M1 or M2 macrophages were quantified as the sum of the percentages of early and late stages of apoptosis. Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate apoptosis. ( e ) Immunoblot analysis of Bax, Mcl-1, Bcl-xL, cleaved caspase-3, cleaved PARP, and β-actin in THP-1-derived M2 macrophages. ( a-e ) CAFs were exposed to apoptotic 344SQ cells (ApoSQ) or necrotic cancer cells (NecSQ) for 20 h. Conditioned medium from CAFs only (CAF CM), exposed to ApoSQ (ApoSQ-CAF CM) or NecSQ (NecSQ-CAF CM) was treated to THP-1- or BMDM-derived M1 and M2 macrophages for the indicated days ( a , b ), or 3 days ( c-e ). ( f ) Heatmap showing differentially expressed macrophage polarization-related genes in THP-1-derived M2 macrophages treated with CM for 3 days ( left ). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers ( right ). Log2 fold-change values (ApoSQ-CAF CM vs. CAF CM). ( g ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in THP-1-derived M2 macrophages treated with CM for 3 days. ( h ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages treated with CM for 3 days. ( i ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages derived from THP-1 cells for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. Data are from one experiment representative of three independent experiments with similar results ( c , f and i left ; e ) or from three independent experiments (mean ± standard error: a , b , d , g , h ; c , f and i right ).
M1 Macrophages, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/M1+Macrophage+Flow+Cytometry+Panel/pmc12781172-58-2-14
Average 94 stars, based on 1 article reviews
m1 macrophages - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec inos antibody
Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the <t>iNOS</t> stained with the <t>iNOS</t> <t>antibody</t> conjugated with FITC.
Inos Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/iNOS+Antibody%2C+anti-mouse%2C+REAfinity/pm36388459-159-10-12
Average 94 stars, based on 1 article reviews
inos antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology rwpe 1 cell supernatant
Epithelial ROS-ZNF24 axis drives MIF transcription and promotes CD74-dependent M1 macrophage polarization. (A–E) CD74 knockdown attenuates MIF-induced M1 macrophage polarization, as assessed by CD86 and iNOS expression (A–B), proinflammatory cytokine secretion (C), and flow cytometry analysis of F4/80 + CD86 + macrophages (D–E). (F–H) LPS stimulation induces MIF mRNA expression (F), protein expression (G), and secretion (H) <t>in</t> <t>RWPE-1</t> prostate epithelial cells. (I–K) Transwell co-culture system showing that LPS-stimulated prostate epithelial cells promote M1 polarization and cytokine secretion in iBMDMs, which is suppressed by the MIF inhibitor ISO-1. (L–M) Increased epithelial oxidative stress in EAP mice and LPS-stimulated RWPE-1 cells, indicated by 8-OHdG staining (L) and intracellular ROS levels (M), respectively; NAC effectively reduces ROS accumulation. (N–O) ROS scavenging with NAC suppresses epithelial MIF expression and attenuates M1 marker expression in co-cultured macrophages. (P–T) ZNF24 is induced by epithelial ROS and directly regulates MIF transcription, as shown by ZNF24 expression (P), ZNF24 knockdown (Q), predicted ZNF24 binding motifs in the MIF promoter (R), and ChIP assays demonstrating enhanced ZNF24 binding upon LPS stimulation (S–T). Data are presented as mean ± SD. ns, not significant; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Abbreviations: iBMDMs, immortalized bone marrow-derived macrophages; RWPE-1, human prostate epithelial cell line; siCD74, small interfering RNA targeting CD74; LPS, lipopolysaccharide; NAC, N-acetylcysteine; ROS, reactive oxygen species.
Rwpe 1 Cell Supernatant, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Human+MIF+(Macrophage+Migration+Inhibitory+Factor)+ELISA+Kit/pmc12859805-91-17-23
Average 94 stars, based on 1 article reviews
rwpe 1 cell supernatant - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems cellxvivo human m1 differentiation kit
Epithelial ROS-ZNF24 axis drives MIF transcription and promotes CD74-dependent M1 macrophage polarization. (A–E) CD74 knockdown attenuates MIF-induced M1 macrophage polarization, as assessed by CD86 and iNOS expression (A–B), proinflammatory cytokine secretion (C), and flow cytometry analysis of F4/80 + CD86 + macrophages (D–E). (F–H) LPS stimulation induces MIF mRNA expression (F), protein expression (G), and secretion (H) <t>in</t> <t>RWPE-1</t> prostate epithelial cells. (I–K) Transwell co-culture system showing that LPS-stimulated prostate epithelial cells promote M1 polarization and cytokine secretion in iBMDMs, which is suppressed by the MIF inhibitor ISO-1. (L–M) Increased epithelial oxidative stress in EAP mice and LPS-stimulated RWPE-1 cells, indicated by 8-OHdG staining (L) and intracellular ROS levels (M), respectively; NAC effectively reduces ROS accumulation. (N–O) ROS scavenging with NAC suppresses epithelial MIF expression and attenuates M1 marker expression in co-cultured macrophages. (P–T) ZNF24 is induced by epithelial ROS and directly regulates MIF transcription, as shown by ZNF24 expression (P), ZNF24 knockdown (Q), predicted ZNF24 binding motifs in the MIF promoter (R), and ChIP assays demonstrating enhanced ZNF24 binding upon LPS stimulation (S–T). Data are presented as mean ± SD. ns, not significant; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Abbreviations: iBMDMs, immortalized bone marrow-derived macrophages; RWPE-1, human prostate epithelial cell line; siCD74, small interfering RNA targeting CD74; LPS, lipopolysaccharide; NAC, N-acetylcysteine; ROS, reactive oxygen species.
Cellxvivo Human M1 Differentiation Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/CellXVivo+Human+M1+Macrophage+Differentiation+Kit/pm34126236-138-14-19
Average 93 stars, based on 1 article reviews
cellxvivo human m1 differentiation kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cusabio elisa kit operation
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Elisa Kit Operation, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Human+Macrophage-Derived+Chemokine+(MDC%2FCCL22)+ELISA+kit/pmc08853541-64-14-17
Average 93 stars, based on 1 article reviews
elisa kit operation - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

88
Biorbyt paraffin sections
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Paraffin Sections, supplied by Biorbyt, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Macrophages+antibody/pm28777474-56-5-11
Average 88 stars, based on 1 article reviews
paraffin sections - by Bioz Stars, 2026-11
88/100 stars
  Buy from Supplier

93
Bio-Rad mouse anti l1cam mac387
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Mouse Anti L1cam Mac387, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Mouse+anti+Human+Macrophages/pmc05495534-168-67-69
Average 93 stars, based on 1 article reviews
mouse anti l1cam mac387 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Bio-Rad mouse anti chicken antibody
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Mouse Anti Chicken Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Mouse+anti+Chicken+Monocytes%2FMacrophages/pmc11598142-86-3-19
Average 93 stars, based on 1 article reviews
mouse anti chicken antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Bio-Rad rat anti mouse monoclonal monocyte macrophage antibody
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Rat Anti Mouse Monoclonal Monocyte Macrophage Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Rat+anti+Mouse+Macrophages%2FMonocytes/pmc03380900-95-15-21
Average 93 stars, based on 1 article reviews
rat anti mouse monoclonal monocyte macrophage antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cedarlane anti mouse macrophage f4 80
A, B: the expression of HOTAIR <t>and</t> <t>CCL22</t> mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by <t>ELISA</t> assay. ****, P<0.001.
Anti Mouse Macrophage F4 80, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/Anti-Mouse+Macrophage+(F4%2F80)%2C+FITC+(Polyclonal)+(chicken+IgY)/pmc02662559-418-12-15
Average 93 stars, based on 1 article reviews
anti mouse macrophage f4 80 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Proteintech mmp12
TAMs reprogrammed by SRC‐1 secretion <t>MMP12</t> induce PNI. A) BMDMs were induced into TAMs from WT and SRC‐1 ‐/‐ mice, and CM was collected for differential protein analysis by mass spectrometry (n = 3). B) Volcano plot of differentially expressed proteins between WT and SRC‐1 ‐/‐ groups. C) qPCR analysis revealed decreased MMP12 mRNA levels upon SRC‐1 downregulation.n = 3. Significance was calculated with Student's t ‐test. **** P< 0.0001. D, E) Western blotting detected the reduced MMP12 protein expression following SRC‐1 down‐regulation. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05. F) Immunofluorescence staining to detect the expression of MMP12 in mouse tissues from the sciatic nerve injection models. G,H) Western blot confirmation demonstrated successful SRC‐1 knockdown and MMP12 over‐expression. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, **** P< 0.0001. I) CCK8 assays were utilized to indicate the enhanced proliferation of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. *** P< 0.001, **** P< 0.0001. J) Rescue experiments assessing changes in in vitro PNI following SRC‐1 down‐regulation and MMP12 over‐expression. The red arrow indicates the leading edge of pancreatic cancer cell invasion. K) The neural invasion index of the rescue experiments. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01. L–O) Wound healing and Trans‐well assays demonstrated the increased migration and invasion ability of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs.n = 3. For wound healing assays: the scale bar is 500 µm. For the Transwell assay, the scale bar is 400 µm.n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P <0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Mmp12, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/MMP12+Antibody/pmc12677693-217-52-53
Average 95 stars, based on 1 article reviews
mmp12 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Proteintech cd206
Sequences of primers.
Cd206, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrophage/CL594-conjugated+CD206+Antibody/pmc11572359-80-41-44
Average 93 stars, based on 1 article reviews
cd206 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


CM from CAFs exposed to apoptotic cancer cells reduces M2 macrophage survival, induces apoptosis, and promotes reprogramming toward an M1 phenotype in vitro . ( a, b ) Cell viability assay of M1 (M1) or M2 macrophages (M2) derived from THP-1 cells and BMDMs. ( c, d ) Apoptotic M1 or M2 macrophages were quantified as the sum of the percentages of early and late stages of apoptosis. Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate apoptosis. ( e ) Immunoblot analysis of Bax, Mcl-1, Bcl-xL, cleaved caspase-3, cleaved PARP, and β-actin in THP-1-derived M2 macrophages. ( a-e ) CAFs were exposed to apoptotic 344SQ cells (ApoSQ) or necrotic cancer cells (NecSQ) for 20 h. Conditioned medium from CAFs only (CAF CM), exposed to ApoSQ (ApoSQ-CAF CM) or NecSQ (NecSQ-CAF CM) was treated to THP-1- or BMDM-derived M1 and M2 macrophages for the indicated days ( a , b ), or 3 days ( c-e ). ( f ) Heatmap showing differentially expressed macrophage polarization-related genes in THP-1-derived M2 macrophages treated with CM for 3 days ( left ). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers ( right ). Log2 fold-change values (ApoSQ-CAF CM vs. CAF CM). ( g ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in THP-1-derived M2 macrophages treated with CM for 3 days. ( h ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages treated with CM for 3 days. ( i ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages derived from THP-1 cells for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. Data are from one experiment representative of three independent experiments with similar results ( c , f and i left ; e ) or from three independent experiments (mean ± standard error: a , b , d , g , h ; c , f and i right ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: CM from CAFs exposed to apoptotic cancer cells reduces M2 macrophage survival, induces apoptosis, and promotes reprogramming toward an M1 phenotype in vitro . ( a, b ) Cell viability assay of M1 (M1) or M2 macrophages (M2) derived from THP-1 cells and BMDMs. ( c, d ) Apoptotic M1 or M2 macrophages were quantified as the sum of the percentages of early and late stages of apoptosis. Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate apoptosis. ( e ) Immunoblot analysis of Bax, Mcl-1, Bcl-xL, cleaved caspase-3, cleaved PARP, and β-actin in THP-1-derived M2 macrophages. ( a-e ) CAFs were exposed to apoptotic 344SQ cells (ApoSQ) or necrotic cancer cells (NecSQ) for 20 h. Conditioned medium from CAFs only (CAF CM), exposed to ApoSQ (ApoSQ-CAF CM) or NecSQ (NecSQ-CAF CM) was treated to THP-1- or BMDM-derived M1 and M2 macrophages for the indicated days ( a , b ), or 3 days ( c-e ). ( f ) Heatmap showing differentially expressed macrophage polarization-related genes in THP-1-derived M2 macrophages treated with CM for 3 days ( left ). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers ( right ). Log2 fold-change values (ApoSQ-CAF CM vs. CAF CM). ( g ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in THP-1-derived M2 macrophages treated with CM for 3 days. ( h ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages treated with CM for 3 days. ( i ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages derived from THP-1 cells for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. Data are from one experiment representative of three independent experiments with similar results ( c , f and i left ; e ) or from three independent experiments (mean ± standard error: a , b , d , g , h ; c , f and i right ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: In Vitro, Viability Assay, Derivative Assay, Flow Cytometry, Staining, Western Blot, Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Fluorescence, Two Tailed Test

ApoSQ-CAF CM activates STAT1 in M2 macrophages. ( a, b ) Immunoblot analysis of the indicated proteins in THP-1-derived M1 (M1) and M2 macrophages (M2) treated with CAF CM or ApoSQ-CAF CM for the indicated time. ( c ) Immunofluorescence staining for phosphorylated STAT1 and p21 ( Left ) and quantitation ( Right ) in M2 macrophages for 1 h after treatment with CAF CM or ApoSQ-CAF CM. The imaging medium was VECTASHIELD fluorescence mounting medium containing DAPI. Original magnification: ×400. Scale bars = 20 μm. ( d ) Immunoblot analysis of STAT1 in M2 macrophages transfected with control or STAT1 siRNA ( upper ). Densitometric analysis of the relative STAT1 abundance ( lower ). ( e ) Cell viability assay of M2 macrophages. ( f ) Left: Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the cell apoptosis of M2 macrophages. Right : Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. ( g ) Immunoblot analysis of the indicated proteins in M2 macrophage lysates. ( h ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages (M2). ( i ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages. ( j ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages. Mean fluorescence intensity (MFI) values ( right ). ( e - j ) THP-1-derived M2 macrophages were transfected with control or STAT1 siRNA for 24 h before treatment with CM for 2 or 3 days. NS: not significant; ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( a , b, g ; c , f , and j left ; d upper ) or from three independent experiments (mean ± standard error in c , f , and j right ; d lower ; e , h , i ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: ApoSQ-CAF CM activates STAT1 in M2 macrophages. ( a, b ) Immunoblot analysis of the indicated proteins in THP-1-derived M1 (M1) and M2 macrophages (M2) treated with CAF CM or ApoSQ-CAF CM for the indicated time. ( c ) Immunofluorescence staining for phosphorylated STAT1 and p21 ( Left ) and quantitation ( Right ) in M2 macrophages for 1 h after treatment with CAF CM or ApoSQ-CAF CM. The imaging medium was VECTASHIELD fluorescence mounting medium containing DAPI. Original magnification: ×400. Scale bars = 20 μm. ( d ) Immunoblot analysis of STAT1 in M2 macrophages transfected with control or STAT1 siRNA ( upper ). Densitometric analysis of the relative STAT1 abundance ( lower ). ( e ) Cell viability assay of M2 macrophages. ( f ) Left: Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the cell apoptosis of M2 macrophages. Right : Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. ( g ) Immunoblot analysis of the indicated proteins in M2 macrophage lysates. ( h ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages (M2). ( i ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages. ( j ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages. Mean fluorescence intensity (MFI) values ( right ). ( e - j ) THP-1-derived M2 macrophages were transfected with control or STAT1 siRNA for 24 h before treatment with CM for 2 or 3 days. NS: not significant; ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( a , b, g ; c , f , and j left ; d upper ) or from three independent experiments (mean ± standard error in c , f , and j right ; d lower ; e , h , i ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: Western Blot, Derivative Assay, Immunofluorescence, Staining, Quantitation Assay, Imaging, Fluorescence, Transfection, Control, Viability Assay, Flow Cytometry, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Two Tailed Test

Recombinant WISP-1 reduces M2 macrophage survival, induces apoptosis, and promotes reprogramming toward an M1-like phenotype. ( a ) Cell viability assay of THP-1-derived M1 (M1) and M2 macrophages (M2) treated with 20-100 ng/ml mouse (rWISP-1) or human WISP-1 ( h rWISP-1) for 3 days. ( b ) Left: Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the apoptosis of THP-1- derived M1 and M2 macrophages after treatment with h rWISP- (20-100 ng/ml) for 3 days. Right : Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. ( c ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages treated with 20-100 ng/ml h rWISP-1 for 3 days. ( d ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages treated with 20-100 ng/ml h rWISP-1 for 3 days. ( e ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages after treatment with h rWISP-1 (20-100 ng/ml) for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). ( f ) Heatmap showing differentially expressed macrophage polarization-related genes in THP-1-derived M2 macrophages ( left ). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers ( right ). Log2 fold-change values ( h rWISP-1 vs. Vehicle). THP-1-derived M2 macrophages were treated with h rWISP-1 (50 ng/ml) for 3 days. NS: not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( b , e , and f left ) or from three independent experiments (mean ± standard error: a , c , d ; b , e and f right ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: Recombinant WISP-1 reduces M2 macrophage survival, induces apoptosis, and promotes reprogramming toward an M1-like phenotype. ( a ) Cell viability assay of THP-1-derived M1 (M1) and M2 macrophages (M2) treated with 20-100 ng/ml mouse (rWISP-1) or human WISP-1 ( h rWISP-1) for 3 days. ( b ) Left: Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the apoptosis of THP-1- derived M1 and M2 macrophages after treatment with h rWISP- (20-100 ng/ml) for 3 days. Right : Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. ( c ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages treated with 20-100 ng/ml h rWISP-1 for 3 days. ( d ) ELISA of TNF-α, IL-1β, IL-4, and IL-13 in the culture supernatant of M2 macrophages treated with 20-100 ng/ml h rWISP-1 for 3 days. ( e ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages after treatment with h rWISP-1 (20-100 ng/ml) for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). ( f ) Heatmap showing differentially expressed macrophage polarization-related genes in THP-1-derived M2 macrophages ( left ). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers ( right ). Log2 fold-change values ( h rWISP-1 vs. Vehicle). THP-1-derived M2 macrophages were treated with h rWISP-1 (50 ng/ml) for 3 days. NS: not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( b , e , and f left ) or from three independent experiments (mean ± standard error: a , c , d ; b , e and f right ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: Recombinant, Viability Assay, Derivative Assay, Flow Cytometry, Staining, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Fluorescence, Expressing, Two Tailed Test

rWISP-1 acts through integrin α5β3 to activate STAT1 in M2 macrophages. ( a , i ) Cell viability assay of M2 macrophages treated with 50 ng/ml human rWISP-1 ( h rWISP-1) for 3 days. ( b , j ) Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the cell apoptosis of M2 macrophages treated with h rWISP-1 for 3 days. ( c , l ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages treated with h rWISP-1 for 3 days. ( d , m ) ELISA of the cytokines (TNFα, IL-1β, IL-4, and IL-13) in the culture supernatants of M2 macrophages treated with h rWISP-1 for 3 days. ( e , n ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages treated with h rWISP-1 for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). ( f ) CoIP assays of protein interaction in M2 macrophages. Cell lysates were immunoprecipitated (IP) with anti-WISP-1 and then immunoblotted with anti-integrin α5 and anti-integrin β3 antibodies. ( g , h ) Immunoblot analysis of phosphorylated and total STAT1 in THP-1-derived M2 macrophages treated with ApoSQ-CAF CM or h rWISP-1 for the indicated time ( g ) or 30 min ( h ). ( k ) Immunoblot analysis of the indicated proteins in M2 macrophages treated with h rWISP-1 for 3 days. ( a-e ) THP-1-derived M2 macrophages were pretreated with an anti-integrin blocking antibody (3 μg/ml; anti-integrin αν, α5, β3 or β5) or corresponding IgG isotype control for 30 min before treatment with rWISP-1 (50 ng/ml). ( i-n ) THP-1-derived M2 macrophages were transfected with control or STAT1 siRNA before treatment with h rWISP-1 (50 ng/ml). NS: not significant; ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( e , j , and n left ; f , g , h , k ) or from three independent experiments (mean ± standard error: a-d , i , l , m ; e , j , and n right ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: rWISP-1 acts through integrin α5β3 to activate STAT1 in M2 macrophages. ( a , i ) Cell viability assay of M2 macrophages treated with 50 ng/ml human rWISP-1 ( h rWISP-1) for 3 days. ( b , j ) Apoptotic cells were quantified as the sum of the percentages of early and late stages of apoptosis. Flow cytometry analysis after Annexin V-FICT/PI dual staining was employed to evaluate the cell apoptosis of M2 macrophages treated with h rWISP-1 for 3 days. ( c , l ) qRT-PCR analysis of relative mRNA levels of M1 ( Nos2 , MhcII , and Il12p40 ) and M2 ( Tgfβ1 , Il10 , and Il4 ) markers in M2 macrophages treated with h rWISP-1 for 3 days. ( d , m ) ELISA of the cytokines (TNFα, IL-1β, IL-4, and IL-13) in the culture supernatants of M2 macrophages treated with h rWISP-1 for 3 days. ( e , n ) Flow cytometry analysis of the population of CD80 + and CD206 + cells among M2 macrophages treated with h rWISP-1 for 2 or 3 days. Mean fluorescence intensity (MFI) values ( right ). ( f ) CoIP assays of protein interaction in M2 macrophages. Cell lysates were immunoprecipitated (IP) with anti-WISP-1 and then immunoblotted with anti-integrin α5 and anti-integrin β3 antibodies. ( g , h ) Immunoblot analysis of phosphorylated and total STAT1 in THP-1-derived M2 macrophages treated with ApoSQ-CAF CM or h rWISP-1 for the indicated time ( g ) or 30 min ( h ). ( k ) Immunoblot analysis of the indicated proteins in M2 macrophages treated with h rWISP-1 for 3 days. ( a-e ) THP-1-derived M2 macrophages were pretreated with an anti-integrin blocking antibody (3 μg/ml; anti-integrin αν, α5, β3 or β5) or corresponding IgG isotype control for 30 min before treatment with rWISP-1 (50 ng/ml). ( i-n ) THP-1-derived M2 macrophages were transfected with control or STAT1 siRNA before treatment with h rWISP-1 (50 ng/ml). NS: not significant; ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. The data are from one experiment representative of three independent experiments with similar results ( e , j , and n left ; f , g , h , k ) or from three independent experiments (mean ± standard error: a-d , i , l , m ; e , j , and n right ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: Viability Assay, Flow Cytometry, Staining, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Fluorescence, Immunoprecipitation, Western Blot, Derivative Assay, Blocking Assay, Control, Transfection, Two Tailed Test

ApoSQ-CAF CM promotes M2-to-M1 TAM reprogramming and activates STAT1 in M2 TAMs via WISP-1. The experimental design was described in Fig. a. ( a ) Heatmap showing differentially expressed genes encoding M1 and M2 marker-related molecules in isolated CD11b + TAMs from primary tumors (left). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers (right). Log2 fold-change values (ApoSQ-CAF CM vs. CAF CM). ( b ) qRT-PCR analysis of relative mRNA levels of M2 markers ( Arg1 , Cd206 , Cd163 , Il4 , Il10 , Tgfβ1 ), and M1 markers ( Tnfα , Cd80 , MhcII , Nos2 , Ifng , and Il12p40 ) in isolated CD11b + TAMs from primary tumors. NS: not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, Analysis of variance with Tukey's post hoc test. ( c ) Immunoblot analysis of Arg1, CD206, iNOS, and CD16/32 in isolated CD11b + TAMs from primary tumors. ( d , e ) Flow cytometry analysis of the population of M1 TAMs (MHCII + and CD80 + ) and M2 TAMs (CD163 + and CD206 + ) in CD11b + TAMs from primary tumors. Mean fluorescence intensity (MFI) values ( right ). ( f ) Upper: Representative flow cytometry plots in CD11b + TAMs. Lower : TAM ratio (CD163 + /MHCII + TAMs). ( g-k ) Flow cytometry analysis of the population of M2 macrophages ( g ), Tregs ( h ), M1 macrophages ( i ), CD8 + T cells ( j ), and CD4 + T cells ( k ). Tumor-infiltrating immune cells were stained with antibodies against CD45, CD11b, CD3, CD4, CD8, FoxP3, MHCII, and Ly6C. Absolute number of each cell type was counted using flow cytometry. ( a , d-k ) NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. ( a - k ) The data are from three replicates per condition, with cells pooled from three mice per replicate. ( l, n ) Representative confocal images of primary tumor sections stained with an anti-phosphorylated STAT1 (red), anti-CD206 antibody (green), anti-iNOS antibody (green), and DAPI (blue). Original magnification: ×40. Scale bars = 100 μm. ( m , o ) Quantification of phosphorylated STAT1 + cells among CD206 + cells and iNOS + cells. NS, not significant; *** P < 0.001, Analysis of variance with Tukey's post hoc test. The data are from one experiment representative of three independent experiments with similar results ( a , d and e left ; c , l , n ; f upper ) or from three independent experiments (mean ± standard error: a , d and e right ; b, g-k , m , o ; f lower ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: ApoSQ-CAF CM promotes M2-to-M1 TAM reprogramming and activates STAT1 in M2 TAMs via WISP-1. The experimental design was described in Fig. a. ( a ) Heatmap showing differentially expressed genes encoding M1 and M2 marker-related molecules in isolated CD11b + TAMs from primary tumors (left). Red: high expression; blue: low expression. Relative expression of selected genes from PCR array profiling of macrophage polarization markers (right). Log2 fold-change values (ApoSQ-CAF CM vs. CAF CM). ( b ) qRT-PCR analysis of relative mRNA levels of M2 markers ( Arg1 , Cd206 , Cd163 , Il4 , Il10 , Tgfβ1 ), and M1 markers ( Tnfα , Cd80 , MhcII , Nos2 , Ifng , and Il12p40 ) in isolated CD11b + TAMs from primary tumors. NS: not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, Analysis of variance with Tukey's post hoc test. ( c ) Immunoblot analysis of Arg1, CD206, iNOS, and CD16/32 in isolated CD11b + TAMs from primary tumors. ( d , e ) Flow cytometry analysis of the population of M1 TAMs (MHCII + and CD80 + ) and M2 TAMs (CD163 + and CD206 + ) in CD11b + TAMs from primary tumors. Mean fluorescence intensity (MFI) values ( right ). ( f ) Upper: Representative flow cytometry plots in CD11b + TAMs. Lower : TAM ratio (CD163 + /MHCII + TAMs). ( g-k ) Flow cytometry analysis of the population of M2 macrophages ( g ), Tregs ( h ), M1 macrophages ( i ), CD8 + T cells ( j ), and CD4 + T cells ( k ). Tumor-infiltrating immune cells were stained with antibodies against CD45, CD11b, CD3, CD4, CD8, FoxP3, MHCII, and Ly6C. Absolute number of each cell type was counted using flow cytometry. ( a , d-k ) NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001, two-tailed Student's t -test. ( a - k ) The data are from three replicates per condition, with cells pooled from three mice per replicate. ( l, n ) Representative confocal images of primary tumor sections stained with an anti-phosphorylated STAT1 (red), anti-CD206 antibody (green), anti-iNOS antibody (green), and DAPI (blue). Original magnification: ×40. Scale bars = 100 μm. ( m , o ) Quantification of phosphorylated STAT1 + cells among CD206 + cells and iNOS + cells. NS, not significant; *** P < 0.001, Analysis of variance with Tukey's post hoc test. The data are from one experiment representative of three independent experiments with similar results ( a , d and e left ; c , l , n ; f upper ) or from three independent experiments (mean ± standard error: a , d and e right ; b, g-k , m , o ; f lower ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: Marker, Isolation, Expressing, Quantitative RT-PCR, Western Blot, Flow Cytometry, Fluorescence, Staining, Two Tailed Test

Administration of rWISP-1 reduces TAM density, decrease the M2 fraction and marker expression, and activates STAT1 in M2 TAMs. The experimental design was described in Supplementary a. Where indicated, rWISP-1 (12.5 and 25 μg/kg) was administered intratumorally three times a week for 6 weeks starting 2 days after subcutaneous implantation of 344SQ cells into syngeneic (129/Sν) mice (n = 6 mice per group). Mice were necropsied 6 weeks later. ( a , b ) Upper : Immunofluorescent staining of primary tumor sections showing M2 TAM Markers Arg1 (green) and CD206 (green), along with the pan-macrophage marker CD11b (red). Original magnification: ×40. Scale bars = 100 μm. Lower : Quantitation of Arg1 + and CD206 + TAM (M2) density ( left ) and the fraction of M2 TAMs ( right ) in primary tumors. The fraction of M2 TAMs were determined by the percentage of M2 TAMs within CD11b + TAMs. ( c ) qRT-PCR analysis of relative mRNA levels of M2 markers ( Arg1 , CD206 , CD163 , IL-4 , IL-10 , TGF-β1 ), and M1 markers ( TNFα , CD80 , MhcII , NOS2, Ifng, and IL-12 p40 ) in isolated CD11b + TAMs from primary tumors. ( d ) Immunoblot analysis of Arg1, CD206, iNOS, and CD16/32 in isolated CD11b + TAMs from primary tumors. ( e, g ) Representative confocal images of primary tumor sections stained with an anti-phosphorylated STAT1 (red), anti-CD206 antibody (green), anti-CD86 antibody (green), and DAPI (blue). Original magnification: ×40. Scale bars = 100 μm. ( f , h ) Quantification of phosphorylated STAT1 + cells among CD206 + cells and CD86 + cells. NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001 compared to Vehicle or as indicated; ### P < 0.001 compared to Vehicle, Analysis of variance with Tukey's post hoc test. The data are from one experiment representative of three independent experiments with similar results ( a and b upper ; d , e , g ). The data are represented as the means ± standard errors from three mice per group ( a and b lower ; c , f , h ).

Journal: International Journal of Biological Sciences

Article Title: Apoptotic Cancer Cell-Primed Cancer-Associated Fibroblasts Suppress Immunosuppressive Macrophages via WISP-1-Integrin α5β3-STAT1 Signaling in Lung Cancer

doi: 10.7150/ijbs.124282

Figure Lengend Snippet: Administration of rWISP-1 reduces TAM density, decrease the M2 fraction and marker expression, and activates STAT1 in M2 TAMs. The experimental design was described in Supplementary a. Where indicated, rWISP-1 (12.5 and 25 μg/kg) was administered intratumorally three times a week for 6 weeks starting 2 days after subcutaneous implantation of 344SQ cells into syngeneic (129/Sν) mice (n = 6 mice per group). Mice were necropsied 6 weeks later. ( a , b ) Upper : Immunofluorescent staining of primary tumor sections showing M2 TAM Markers Arg1 (green) and CD206 (green), along with the pan-macrophage marker CD11b (red). Original magnification: ×40. Scale bars = 100 μm. Lower : Quantitation of Arg1 + and CD206 + TAM (M2) density ( left ) and the fraction of M2 TAMs ( right ) in primary tumors. The fraction of M2 TAMs were determined by the percentage of M2 TAMs within CD11b + TAMs. ( c ) qRT-PCR analysis of relative mRNA levels of M2 markers ( Arg1 , CD206 , CD163 , IL-4 , IL-10 , TGF-β1 ), and M1 markers ( TNFα , CD80 , MhcII , NOS2, Ifng, and IL-12 p40 ) in isolated CD11b + TAMs from primary tumors. ( d ) Immunoblot analysis of Arg1, CD206, iNOS, and CD16/32 in isolated CD11b + TAMs from primary tumors. ( e, g ) Representative confocal images of primary tumor sections stained with an anti-phosphorylated STAT1 (red), anti-CD206 antibody (green), anti-CD86 antibody (green), and DAPI (blue). Original magnification: ×40. Scale bars = 100 μm. ( f , h ) Quantification of phosphorylated STAT1 + cells among CD206 + cells and CD86 + cells. NS, not significant; * P < 0.05, ** P < 0.01, *** P < 0.001 compared to Vehicle or as indicated; ### P < 0.001 compared to Vehicle, Analysis of variance with Tukey's post hoc test. The data are from one experiment representative of three independent experiments with similar results ( a and b upper ; d , e , g ). The data are represented as the means ± standard errors from three mice per group ( a and b lower ; c , f , h ).

Article Snippet: To establish M1 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml of IFN-γ (R&D Systems) and 100 ng/ml of lipopolysaccharide (Sigma-Aldrich) for an additional 48 h. To establish M2 macrophages, the unpolarized macrophages were stimulated with 20 ng/ml IL-4 and 20 ng/ml IL-13 (R&D Systems) for an additional 48 h. Following polarization, cells were harvested for immunoblot analysis or fixed for immunofluorescent staining.

Techniques: Marker, Expressing, Staining, Quantitation Assay, Quantitative RT-PCR, Isolation, Western Blot

Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Journal: Materials today. Bio

Article Title: Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy.

doi: 10.1016/j.mtbio.2022.100482

Figure Lengend Snippet: Fig. 10. Immunostaining of tumor tissues in tumor-bearing mice after treatments. (A) Immunohistochemistry images of tumor sections stained with CD3, CD8, and TNF-α antibodies. The scale bar is 100 μm. (B) Immunofluorescence images of tumor tissues after treatments for 12 days. The scale bar is 50 μm. Blue fluorescence represents the cell nucleus stained with DAPI. Green fluorescence represents the iNOS stained with the iNOS antibody conjugated with FITC.

Article Snippet: After 30 min, the tissue slice was stained with diluted iNOS antibody (Miltenyi Biotec, catalog: 130-116-357) at 4 C overnight.

Techniques: Immunostaining, Immunohistochemistry, Staining

Epithelial ROS-ZNF24 axis drives MIF transcription and promotes CD74-dependent M1 macrophage polarization. (A–E) CD74 knockdown attenuates MIF-induced M1 macrophage polarization, as assessed by CD86 and iNOS expression (A–B), proinflammatory cytokine secretion (C), and flow cytometry analysis of F4/80 + CD86 + macrophages (D–E). (F–H) LPS stimulation induces MIF mRNA expression (F), protein expression (G), and secretion (H) in RWPE-1 prostate epithelial cells. (I–K) Transwell co-culture system showing that LPS-stimulated prostate epithelial cells promote M1 polarization and cytokine secretion in iBMDMs, which is suppressed by the MIF inhibitor ISO-1. (L–M) Increased epithelial oxidative stress in EAP mice and LPS-stimulated RWPE-1 cells, indicated by 8-OHdG staining (L) and intracellular ROS levels (M), respectively; NAC effectively reduces ROS accumulation. (N–O) ROS scavenging with NAC suppresses epithelial MIF expression and attenuates M1 marker expression in co-cultured macrophages. (P–T) ZNF24 is induced by epithelial ROS and directly regulates MIF transcription, as shown by ZNF24 expression (P), ZNF24 knockdown (Q), predicted ZNF24 binding motifs in the MIF promoter (R), and ChIP assays demonstrating enhanced ZNF24 binding upon LPS stimulation (S–T). Data are presented as mean ± SD. ns, not significant; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Abbreviations: iBMDMs, immortalized bone marrow-derived macrophages; RWPE-1, human prostate epithelial cell line; siCD74, small interfering RNA targeting CD74; LPS, lipopolysaccharide; NAC, N-acetylcysteine; ROS, reactive oxygen species.

Journal: Redox Biology

Article Title: Epithelial redox stress programs macrophage immunometabolism through a ZNF24-MIF–NF–κB pathway in chronic nonbacterial prostatitis

doi: 10.1016/j.redox.2026.104042

Figure Lengend Snippet: Epithelial ROS-ZNF24 axis drives MIF transcription and promotes CD74-dependent M1 macrophage polarization. (A–E) CD74 knockdown attenuates MIF-induced M1 macrophage polarization, as assessed by CD86 and iNOS expression (A–B), proinflammatory cytokine secretion (C), and flow cytometry analysis of F4/80 + CD86 + macrophages (D–E). (F–H) LPS stimulation induces MIF mRNA expression (F), protein expression (G), and secretion (H) in RWPE-1 prostate epithelial cells. (I–K) Transwell co-culture system showing that LPS-stimulated prostate epithelial cells promote M1 polarization and cytokine secretion in iBMDMs, which is suppressed by the MIF inhibitor ISO-1. (L–M) Increased epithelial oxidative stress in EAP mice and LPS-stimulated RWPE-1 cells, indicated by 8-OHdG staining (L) and intracellular ROS levels (M), respectively; NAC effectively reduces ROS accumulation. (N–O) ROS scavenging with NAC suppresses epithelial MIF expression and attenuates M1 marker expression in co-cultured macrophages. (P–T) ZNF24 is induced by epithelial ROS and directly regulates MIF transcription, as shown by ZNF24 expression (P), ZNF24 knockdown (Q), predicted ZNF24 binding motifs in the MIF promoter (R), and ChIP assays demonstrating enhanced ZNF24 binding upon LPS stimulation (S–T). Data are presented as mean ± SD. ns, not significant; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Abbreviations: iBMDMs, immortalized bone marrow-derived macrophages; RWPE-1, human prostate epithelial cell line; siCD74, small interfering RNA targeting CD74; LPS, lipopolysaccharide; NAC, N-acetylcysteine; ROS, reactive oxygen species.

Article Snippet: MIF levels were quantified in NOD mouse serum (Cat. No. E-EL-M0771, Elabscience) and in human serum and RWPE-1 cell supernatant (Cat. No. E-EL-H6170, Elabscience).

Techniques: Knockdown, Expressing, Flow Cytometry, Co-Culture Assay, Staining, Marker, Cell Culture, Binding Assay, Derivative Assay, Small Interfering RNA

A, B: the expression of HOTAIR and CCL22 mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by ELISA assay. ****, P<0.001.

Journal: PLoS ONE

Article Title: LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway

doi: 10.1371/journal.pone.0263997

Figure Lengend Snippet: A, B: the expression of HOTAIR and CCL22 mRNA were detected by RT-qPCR. C: CCL22 protein analyzed by ELISA assay. ****, P<0.001.

Article Snippet: The concentration of CCL22 in the supernatant was tested according to the instructions of ELISA kit operation (CUSABIO, CSB-E04660h).

Techniques: Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

A: The HOTAIR and CCL22 mRNA expression examined by RT-qPCR B: Cell apoptosis detected by Flow cytometry. C: The cell proliferation tested by MTS assay. D: The CCL22 protein expression tested by ELISA. E: The cell migration and invasion detected by Transwell assay. **, P<0.05; ***, P<0.01; ****, P<0.001;ns, no significance.

Journal: PLoS ONE

Article Title: LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway

doi: 10.1371/journal.pone.0263997

Figure Lengend Snippet: A: The HOTAIR and CCL22 mRNA expression examined by RT-qPCR B: Cell apoptosis detected by Flow cytometry. C: The cell proliferation tested by MTS assay. D: The CCL22 protein expression tested by ELISA. E: The cell migration and invasion detected by Transwell assay. **, P<0.05; ***, P<0.01; ****, P<0.001;ns, no significance.

Article Snippet: The concentration of CCL22 in the supernatant was tested according to the instructions of ELISA kit operation (CUSABIO, CSB-E04660h).

Techniques: Expressing, Quantitative RT-PCR, Flow Cytometry, MTS Assay, Enzyme-linked Immunosorbent Assay, Migration, Transwell Assay

TAMs reprogrammed by SRC‐1 secretion MMP12 induce PNI. A) BMDMs were induced into TAMs from WT and SRC‐1 ‐/‐ mice, and CM was collected for differential protein analysis by mass spectrometry (n = 3). B) Volcano plot of differentially expressed proteins between WT and SRC‐1 ‐/‐ groups. C) qPCR analysis revealed decreased MMP12 mRNA levels upon SRC‐1 downregulation.n = 3. Significance was calculated with Student's t ‐test. **** P< 0.0001. D, E) Western blotting detected the reduced MMP12 protein expression following SRC‐1 down‐regulation. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05. F) Immunofluorescence staining to detect the expression of MMP12 in mouse tissues from the sciatic nerve injection models. G,H) Western blot confirmation demonstrated successful SRC‐1 knockdown and MMP12 over‐expression. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, **** P< 0.0001. I) CCK8 assays were utilized to indicate the enhanced proliferation of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. *** P< 0.001, **** P< 0.0001. J) Rescue experiments assessing changes in in vitro PNI following SRC‐1 down‐regulation and MMP12 over‐expression. The red arrow indicates the leading edge of pancreatic cancer cell invasion. K) The neural invasion index of the rescue experiments. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01. L–O) Wound healing and Trans‐well assays demonstrated the increased migration and invasion ability of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs.n = 3. For wound healing assays: the scale bar is 500 µm. For the Transwell assay, the scale bar is 400 µm.n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P <0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Advanced Science

Article Title: Steroid Receptor Coactivator‐1 Drives Tumor‐Associated Macrophage Reprogramming by Mediating MMP12 Transcription in Pancreatic Cancer Perineural Invasion

doi: 10.1002/advs.202416575

Figure Lengend Snippet: TAMs reprogrammed by SRC‐1 secretion MMP12 induce PNI. A) BMDMs were induced into TAMs from WT and SRC‐1 ‐/‐ mice, and CM was collected for differential protein analysis by mass spectrometry (n = 3). B) Volcano plot of differentially expressed proteins between WT and SRC‐1 ‐/‐ groups. C) qPCR analysis revealed decreased MMP12 mRNA levels upon SRC‐1 downregulation.n = 3. Significance was calculated with Student's t ‐test. **** P< 0.0001. D, E) Western blotting detected the reduced MMP12 protein expression following SRC‐1 down‐regulation. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05. F) Immunofluorescence staining to detect the expression of MMP12 in mouse tissues from the sciatic nerve injection models. G,H) Western blot confirmation demonstrated successful SRC‐1 knockdown and MMP12 over‐expression. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, **** P< 0.0001. I) CCK8 assays were utilized to indicate the enhanced proliferation of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. *** P< 0.001, **** P< 0.0001. J) Rescue experiments assessing changes in in vitro PNI following SRC‐1 down‐regulation and MMP12 over‐expression. The red arrow indicates the leading edge of pancreatic cancer cell invasion. K) The neural invasion index of the rescue experiments. n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01. L–O) Wound healing and Trans‐well assays demonstrated the increased migration and invasion ability of AsPC‐1 cells upon SRC‐1 down‐regulation and MMP12 over‐expression in TAMs.n = 3. For wound healing assays: the scale bar is 500 µm. For the Transwell assay, the scale bar is 400 µm.n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P <0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Wet transfer was performed at 350 mA for 1.5 h. The membrane was blocked with 5% non‐fat dry milk at room temperature(25 °C) for 1.5 h. Primary antibodies were diluted according to recommended ratios: SRC‐1 (CST, 2191, 1:1000), CD206 (Proteintech, 60 143, 1:5000), CD163 (WANLEI, WL03026, 1:1000), iNOS (Proteintech, 22 226, 1:1000), MMP12 (Proteintech, 22 989, 1:500), STAT1 (CST, 9172, 1:1000), p‐STAT1 (CST, 7649, 1:1000), and GAPDH (Proteintech, 10 494, 1:5000).

Techniques: Mass Spectrometry, Western Blot, Expressing, Immunofluorescence, Staining, Injection, Knockdown, Over Expression, In Vitro, Migration, Transwell Assay

SRC‐1 as a coactivator of STAT1, promotes MMP12 promoter activity. A, B) Western blot analysis of p‐STAT1 and STAT1 expression in TAMs under different treatments. n = 3. Significance was calculated with Student's t ‐test. * P< 0.05. C, D) Western blot analysis of p‐NF‐κB, NF‐κB, IRF4, and PPAR‐γ expression in TAMs under different treatments.n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01, ns, no significant difference. E, F) Co‐immunoprecipitation experiments detecting the interaction between SRC‐1 and STAT1. n = 3. Significance was calculated with Student's t ‐test. * P< 0.05, ** P< 0.01, *** P< 0.001. G) Immunofluorescence validation of co‐localization of STAT1 (green) and SRC‐1 (red) in TAMs. H) Prediction by Jaspar of STAT1 binding sites on the MMP12 promoter region. I, J) ChIP assay confirming recruitment of STAT1 to the MMP12 promoter region. K, L) Luciferase assays demonstrating changes in MMP12 promoter luciferase activity upon knockdown or over‐expression of SRC‐1. n = 3. Significance was calculated with Student's t ‐test. * P < 0.05, ** P < 0.01.

Journal: Advanced Science

Article Title: Steroid Receptor Coactivator‐1 Drives Tumor‐Associated Macrophage Reprogramming by Mediating MMP12 Transcription in Pancreatic Cancer Perineural Invasion

doi: 10.1002/advs.202416575

Figure Lengend Snippet: SRC‐1 as a coactivator of STAT1, promotes MMP12 promoter activity. A, B) Western blot analysis of p‐STAT1 and STAT1 expression in TAMs under different treatments. n = 3. Significance was calculated with Student's t ‐test. * P< 0.05. C, D) Western blot analysis of p‐NF‐κB, NF‐κB, IRF4, and PPAR‐γ expression in TAMs under different treatments.n = 3. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01, ns, no significant difference. E, F) Co‐immunoprecipitation experiments detecting the interaction between SRC‐1 and STAT1. n = 3. Significance was calculated with Student's t ‐test. * P< 0.05, ** P< 0.01, *** P< 0.001. G) Immunofluorescence validation of co‐localization of STAT1 (green) and SRC‐1 (red) in TAMs. H) Prediction by Jaspar of STAT1 binding sites on the MMP12 promoter region. I, J) ChIP assay confirming recruitment of STAT1 to the MMP12 promoter region. K, L) Luciferase assays demonstrating changes in MMP12 promoter luciferase activity upon knockdown or over‐expression of SRC‐1. n = 3. Significance was calculated with Student's t ‐test. * P < 0.05, ** P < 0.01.

Article Snippet: Wet transfer was performed at 350 mA for 1.5 h. The membrane was blocked with 5% non‐fat dry milk at room temperature(25 °C) for 1.5 h. Primary antibodies were diluted according to recommended ratios: SRC‐1 (CST, 2191, 1:1000), CD206 (Proteintech, 60 143, 1:5000), CD163 (WANLEI, WL03026, 1:1000), iNOS (Proteintech, 22 226, 1:1000), MMP12 (Proteintech, 22 989, 1:500), STAT1 (CST, 9172, 1:1000), p‐STAT1 (CST, 7649, 1:1000), and GAPDH (Proteintech, 10 494, 1:5000).

Techniques: Activity Assay, Western Blot, Expressing, Immunoprecipitation, Immunofluorescence, Biomarker Discovery, Binding Assay, Luciferase, Knockdown, Over Expression

Inhibition of MMP12 can effectively alleviate PNI both in vivo and in vitro. A, B) Paralysis severity in the hind limbs of mice from various groups following sciatic nerve co‐injection of tumor and macrophage mixtures. Groups: (1) WT BMDM, (2) SRC‐1‐KO BMDM, (3) WT BMDM + vehicle, and (4) WT BMDM + MMP408 (5 mg/kg). n = 19 C) Tumor growth and invasion in the sciatic nerve of mice were recorded. D) Body weight changes in mice over a 21‐day period following sciatic nerve co‐injection of tumor and macrophage mixtures were recorded. E) Sciatic functional index in mice over 21 days following co‐injection of tumor and macrophage mixtures was recorded. WT‐BMDM+KRAS/p53 /m/+ group: n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test at the final time point. ** P< 0.01. F) Sciatic functional scores in mice over 21 days following co‐injection of tumor and macrophage mixtures were recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test at the final time point. **** P< 0.0001. G) Tumor weight in mice harvested at 21 days post‐injection was recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01, ns, no significant difference. H) The length of invasion in the mouse groups was recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. ** P< 0.01. I) Quantitative analysis of CD206 + SRC‐1 + dual‐positive cells was performed in murine tissue using dual‐immunofluorescence staining.WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with Student's t ‐test. * P< 0.05. J) Neural invasion index was recorded in the DRG‐tumor cells co‐culture assay. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. ** P< 0.01, *** P< 0.001. K) Multiplex immunofluorescence co‐staining demonstrating expression of SRC‐1 (red), CD206 (yellow), and S100β (green) in murine tumor tissues. L) A DRG and tumor cell (red) co‐culture model was utilized to quantitatively assess tumor cell PNI capacity ex vivo.

Journal: Advanced Science

Article Title: Steroid Receptor Coactivator‐1 Drives Tumor‐Associated Macrophage Reprogramming by Mediating MMP12 Transcription in Pancreatic Cancer Perineural Invasion

doi: 10.1002/advs.202416575

Figure Lengend Snippet: Inhibition of MMP12 can effectively alleviate PNI both in vivo and in vitro. A, B) Paralysis severity in the hind limbs of mice from various groups following sciatic nerve co‐injection of tumor and macrophage mixtures. Groups: (1) WT BMDM, (2) SRC‐1‐KO BMDM, (3) WT BMDM + vehicle, and (4) WT BMDM + MMP408 (5 mg/kg). n = 19 C) Tumor growth and invasion in the sciatic nerve of mice were recorded. D) Body weight changes in mice over a 21‐day period following sciatic nerve co‐injection of tumor and macrophage mixtures were recorded. E) Sciatic functional index in mice over 21 days following co‐injection of tumor and macrophage mixtures was recorded. WT‐BMDM+KRAS/p53 /m/+ group: n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test at the final time point. ** P< 0.01. F) Sciatic functional scores in mice over 21 days following co‐injection of tumor and macrophage mixtures were recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test at the final time point. **** P< 0.0001. G) Tumor weight in mice harvested at 21 days post‐injection was recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. * P< 0.05, ** P< 0.01, ns, no significant difference. H) The length of invasion in the mouse groups was recorded. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. ** P< 0.01. I) Quantitative analysis of CD206 + SRC‐1 + dual‐positive cells was performed in murine tissue using dual‐immunofluorescence staining.WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with Student's t ‐test. * P< 0.05. J) Neural invasion index was recorded in the DRG‐tumor cells co‐culture assay. WT‐BMDM+KRAS/p53 /m/+ group:n = 4, the other groups:n = 5. Significance was calculated with one‐way ANOVA with Tukey post‐test. ** P< 0.01, *** P< 0.001. K) Multiplex immunofluorescence co‐staining demonstrating expression of SRC‐1 (red), CD206 (yellow), and S100β (green) in murine tumor tissues. L) A DRG and tumor cell (red) co‐culture model was utilized to quantitatively assess tumor cell PNI capacity ex vivo.

Article Snippet: Wet transfer was performed at 350 mA for 1.5 h. The membrane was blocked with 5% non‐fat dry milk at room temperature(25 °C) for 1.5 h. Primary antibodies were diluted according to recommended ratios: SRC‐1 (CST, 2191, 1:1000), CD206 (Proteintech, 60 143, 1:5000), CD163 (WANLEI, WL03026, 1:1000), iNOS (Proteintech, 22 226, 1:1000), MMP12 (Proteintech, 22 989, 1:500), STAT1 (CST, 9172, 1:1000), p‐STAT1 (CST, 7649, 1:1000), and GAPDH (Proteintech, 10 494, 1:5000).

Techniques: Inhibition, In Vivo, In Vitro, Injection, Functional Assay, Immunofluorescence, Staining, Co-culture Assay, Multiplex Assay, Expressing, Co-Culture Assay, Ex Vivo

Schematic illustrating working model for the mechanisms by which SRC‐1 drives TAMs reprogramming by mediating MMP12 transcription in pancreatic cancer PNI. SRC‐1 binds to STAT1 to enhance the transcriptional activity of the MMP12 promoter, thereby increasing MMP12 secretion from TAMs.

Journal: Advanced Science

Article Title: Steroid Receptor Coactivator‐1 Drives Tumor‐Associated Macrophage Reprogramming by Mediating MMP12 Transcription in Pancreatic Cancer Perineural Invasion

doi: 10.1002/advs.202416575

Figure Lengend Snippet: Schematic illustrating working model for the mechanisms by which SRC‐1 drives TAMs reprogramming by mediating MMP12 transcription in pancreatic cancer PNI. SRC‐1 binds to STAT1 to enhance the transcriptional activity of the MMP12 promoter, thereby increasing MMP12 secretion from TAMs.

Article Snippet: Wet transfer was performed at 350 mA for 1.5 h. The membrane was blocked with 5% non‐fat dry milk at room temperature(25 °C) for 1.5 h. Primary antibodies were diluted according to recommended ratios: SRC‐1 (CST, 2191, 1:1000), CD206 (Proteintech, 60 143, 1:5000), CD163 (WANLEI, WL03026, 1:1000), iNOS (Proteintech, 22 226, 1:1000), MMP12 (Proteintech, 22 989, 1:500), STAT1 (CST, 9172, 1:1000), p‐STAT1 (CST, 7649, 1:1000), and GAPDH (Proteintech, 10 494, 1:5000).

Techniques: Activity Assay

Sequences of primers.

Journal: PeerJ

Article Title: Cirsilineol improves anesthesia/surgery-induced postoperative cognitive dysfunction through attenuating oxidative stress and modulating microglia M1/M2 polarization

doi: 10.7717/peerj.18507

Figure Lengend Snippet: Sequences of primers.

Article Snippet: Following washing with PBS, the brain tissues and BV-2 cells were incubated with the blocking buffer at 4 °C for 1 h and the primary antibodies against Iba-1 (019-19741; 1:1,000, Wako Fujifilm, Osaka, Japan), CD86 (942-RBM-4-P1; 1:1,000, Thermo Fisher Scientific) and CD206 (CL594-60143; 1:100, Proteintech, Wuhan, China) at 4 °C overnight.

Techniques: Sequencing

(A and B) Iba-1 + cells in each group of mice based on the quantification on the fluorescence intensity in immunofluorescence assay. (C and D) The calculated levels of microglia polarization indicators Cd86 (M1) and Cd206 (M2). (E and F) The gauged levels of SOD and MDA in plasm of mice in each group. Results were expressed as mean ± standard deviation. ns represents non-significant; P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: PeerJ

Article Title: Cirsilineol improves anesthesia/surgery-induced postoperative cognitive dysfunction through attenuating oxidative stress and modulating microglia M1/M2 polarization

doi: 10.7717/peerj.18507

Figure Lengend Snippet: (A and B) Iba-1 + cells in each group of mice based on the quantification on the fluorescence intensity in immunofluorescence assay. (C and D) The calculated levels of microglia polarization indicators Cd86 (M1) and Cd206 (M2). (E and F) The gauged levels of SOD and MDA in plasm of mice in each group. Results were expressed as mean ± standard deviation. ns represents non-significant; P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: Following washing with PBS, the brain tissues and BV-2 cells were incubated with the blocking buffer at 4 °C for 1 h and the primary antibodies against Iba-1 (019-19741; 1:1,000, Wako Fujifilm, Osaka, Japan), CD86 (942-RBM-4-P1; 1:1,000, Thermo Fisher Scientific) and CD206 (CL594-60143; 1:100, Proteintech, Wuhan, China) at 4 °C overnight.

Techniques: Fluorescence, Immunofluorescence, Standard Deviation

(A–D) Quantified CD86 MFI (A, C) and CD206 MFI (B, D) in each group based on immunofluorescence assay. (E, F) The gauged levels of SOD and MDA in the supernatant of cell culture medium in each group. Results were expressed as mean ± standard deviation. ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: PeerJ

Article Title: Cirsilineol improves anesthesia/surgery-induced postoperative cognitive dysfunction through attenuating oxidative stress and modulating microglia M1/M2 polarization

doi: 10.7717/peerj.18507

Figure Lengend Snippet: (A–D) Quantified CD86 MFI (A, C) and CD206 MFI (B, D) in each group based on immunofluorescence assay. (E, F) The gauged levels of SOD and MDA in the supernatant of cell culture medium in each group. Results were expressed as mean ± standard deviation. ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: Following washing with PBS, the brain tissues and BV-2 cells were incubated with the blocking buffer at 4 °C for 1 h and the primary antibodies against Iba-1 (019-19741; 1:1,000, Wako Fujifilm, Osaka, Japan), CD86 (942-RBM-4-P1; 1:1,000, Thermo Fisher Scientific) and CD206 (CL594-60143; 1:100, Proteintech, Wuhan, China) at 4 °C overnight.

Techniques: Immunofluorescence, Cell Culture, Standard Deviation